Skip to content

Meyka

    Meyka
    • Mark Cuban’s Latest Bet: A Healthcare Plan That Just Might Deliver
      Market News

      Mark Cuban’s Latest Bet: A Healthcare Plan That Just Might Deliver

      ByAmna Habib June 18, 2025June 18, 2025

      Billionaire entrepreneur Mark Cuban has shifted his attention from basketball and TV to a bold healthcare venture, aiming to dismantle inefficiencies and sky-high costs in the US system. His latest effort scales up cost-plus drugs into obesity and chronic disease management, and he’s even floated radical ideas on insurance reform. Could this be the catalyst…

      Read More Mark Cuban’s Latest Bet: A Healthcare Plan That Just Might DeliverContinue

    • Oracle Stock Soars $116 Billion, But Oracle’s AI Gamble Is Now Under the Microscope
      US Stocks

      Oracle Stock Soars $116 Billion, But Oracle’s AI Gamble Is Now Under the Microscope

      ByAmna Habib June 17, 2025June 17, 2025

      The AI race has a new front runner, at least for now. Oracle Corporation stunned the markets after its shares surged nearly 14% in a single day, adding around $116 billion to its market cap. This spike followed a better-than-expected Q4 earnings report and a forecast for cloud infrastructure growth. With Wall Street cheering on…

      Read More Oracle Stock Soars $116 Billion, But Oracle’s AI Gamble Is Now Under the MicroscopeContinue

    • Rolls-Royce
      US Stocks

      Rolls-Royce “Even More True” on Narrowbody Engine Ambitions Ahead

      ByZain June 17, 2025June 17, 2025

      Rolls-Royce is turning heads with its big push into the narrowbody plane market. On June 17, CEO Tufan Erginbilgic shared plans to join this busy aviation segment, likely through a partnership. This move could lead to a new plane by 2035, using their UltraFan tech, with a big £3 billion ($4.1 billion) investment behind it….

      Read More Rolls-Royce “Even More True” on Narrowbody Engine Ambitions AheadContinue

    • Prominent 10
      Market

      Goldman Sachs Identifies China’s ‘Prominent 10’ as Potential ‘Magnificent Seven’ Equivalents

      ByAhmad Dilshad June 17, 2025June 17, 2025

      China’s stock market is getting attention again. This time, Goldman Sachs is leading the direction.. The firm just named China’s “Prominent 10” – a group of companies they believe could match the success of America’s famous “Magnificent Seven.” We all know how U.S. Major companies such as Apple, Microsoft, and NVIDIA have driven market growth….

      Read More Goldman Sachs Identifies China’s ‘Prominent 10’ as Potential ‘Magnificent Seven’ EquivalentsContinue

    • Why Nvidia Stock Jumped on Monday, Putting Record High Back on Radar
      US Stocks

      Why Nvidia Stock Jumped on Monday, Putting Record High Back on Radar

      ByAmna Habib June 17, 2025June 17, 2025

      Nvidia stock jumped about 2% on Monday, bringing the AI-chip giant closer to its all-time high. This positive movement has reignited investor excitement as tech stocks continue to rally. Nvidia’s gains followed recent market dips and were powered by renewed optimism in the artificial intelligence space, particularly from global developments.  The company remains at the…

      Read More Why Nvidia Stock Jumped on Monday, Putting Record High Back on RadarContinue

    • Dow Futures Fall
      Market

      Dow, S&P 500, Nasdaq Futures Market Fall as Trump’s Remarks Stoke Mideast Conflict

      ByZain June 17, 2025June 17, 2025

      Dow futures fall as markets react to rising tensions. On Tuesday, US stock futures took a hit after President Trump’s comments dashed hopes for a quick end to the Israel-Iran conflict. Investors grew cautious, pushing Dow futures down 0.5% to 0.6%, S&P 500 futures 0.4% to 0.7%, and Nasdaq 100 futures 0.5% to 0.8%. Oil…

      Read More Dow, S&P 500, Nasdaq Futures Market Fall as Trump’s Remarks Stoke Mideast ConflictContinue

    • Commodity Channel Index (CCI): How to Find Overbought/Oversold Conditions
      Learning

      Commodity Channel Index (CCI): How to Find Overbought/Oversold Conditions

      ByAmna Habib June 17, 2025June 17, 2025

      The Commodity Channel Index (CCI) is a versatile momentum oscillator, created in 1980 by Donald Lambert. While originally intended for commodities, it is now commonly used across equities, forex, and indices to identify potential turning points. The CCI helps traders spot overbought and oversold conditions, making it a valuable component in timing market entries and…

      Read More Commodity Channel Index (CCI): How to Find Overbought/Oversold ConditionsContinue

    • Amex Platinum Card vs. JPMorgan: Luxury Credit Card Rivalry Heats Up with New Updates
      US Stocks

      Amex Platinum Card vs. JPMorgan: Luxury Credit Card Rivalry Heats Up with New Updates

      ByAmna Habib June 17, 2025June 17, 2025

      The Amex Platinum Card continues to define luxury credit cards, and now it’s facing fresh competition. American Express has announced its biggest update ever for both consumer and business Platinum cards, prompting JPMorgan Chase to accelerate its Sapphire Reserve refresh and roll out a business working. With steep annual fees and high expectations, this rivalry…

      Read More Amex Platinum Card vs. JPMorgan: Luxury Credit Card Rivalry Heats Up with New UpdatesContinue

    • Goldman Reports
      Business

      Hedge Funds Hit Highest Asia Exposure in Five Years, Goldman Reports

      ByZain June 17, 2025June 17, 2025

      Hedge funds are diving deeper into Asian markets, with Goldman Reports highlighting their highest exposure in five years. Between June 6 and June 12, global hedge funds ramped up trading volumes, pushing bullish positions to levels not seen since September 2024. This surge, driven by strategic buys in Japan, Hong Kong, Taiwan, and India, signals…

      Read More Hedge Funds Hit Highest Asia Exposure in Five Years, Goldman ReportsContinue

    • Sarepta Therapeutics Stock Tumbles 42% Following Second Drug‑Linked Death Report
      US Stocks

      Sarepta Therapeutics Stock Tumbles 42% Following Second Drug‑Linked Death Report

      ByAmna Habib June 17, 2025June 17, 2025

      Shares of Sarepta Therapeutics Stock tumbled 42% after the biotech company reported a second death connected to its Duchenne muscular dystrophy (DMD) gene therapy, Elevidys. The news rattled investors, erasing market value and dragging the stock to nine-year lows. This second fatality has raised serious concerns over the safety of the drug, especially for non-ambulatory…

      Read More Sarepta Therapeutics Stock Tumbles 42% Following Second Drug‑Linked Death ReportContinue

    Page navigation

    Previous PagePrevious 1 … 4,816 4,817 4,818 4,819 4,820 … 4,868 Next PageNext

    © 2026 Meyka - WordPress Theme by Kadence WP